Citigroup »

Fennec Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $52k 4.7k 11.15
2023-12-31 $31k 2.7k 11.50
2023-09-30 $822 110 7.48
2023-03-31 $151k 19k 8.13
2022-12-31 $163k 17k 9.66
2021-03-31 $9.0k 1.4k 6.25
2020-12-31 $30k 4.1k 7.24
2020-09-30 $6.0k 1.0k 5.84
2020-06-30 $24k 2.9k 8.28
2020-03-31 $7.0k 1.1k 6.26
2019-09-30 $6.0k 1.3k 4.59
2019-06-30 $8.0k 1.8k 4.51
2019-03-31 $15k 3.3k 4.59
2018-12-31 $19k 3.0k 6.33
2018-09-30 $26k 3.2k 8.18
2018-06-30 $17k 1.6k 10.44